Clinical Trial Update: A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial Dysfunction [Phase 1]

View source ↗

Summary

Phase 1 safety and efficacy results were reported for corneal endothelial cell therapy delivered by corneal injection to treat corneal edema due to endothelial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Edema

Drugs mentioned

• Human Corneal Endothelial Cell Therapy (human corneal endothelial cells)

Snippet

Sponsor: Aurion Biotech | Conditions: Corneal Edema | Phase 1 | Status: COMPLETED